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Eric Dubois, MD,  and David M. Larson, PhD, Boston, Mass. 
Purpose: Endothelial cells (EC) secrete vasoactive eicosanoids, which maintain organ blood 
flow. Because EC are a major source ofeicosanoids, we studied the effects ofreoxygenation 
on EC prostacyclin production. 
Methods: Bovine aortic EC cultures were exposed to 2 hours of normoxia, then 1 hour of 
hypoxia (Po 2 = 10 -+ 3.5 mm Hg), followed by 1.5 hours of reoxygenation i  either 
normal medium or medium plus either superoxide dismutase (SOD, 300 units/ml), 
catalase (1200 units/ml), allopurinol (5.0 x 10-* mol/L), or dinitrophenol (10-4 mol/L). 
Results: Prostacyclin production decreased to 40% (p < 0.05) of basal prostacyclin 
production after I hour of hypoxia. EC reoxygenated with control medium recovered to 
48% of basal prostacyclin production. EC reoxygenated in SOD resulted in recovery 
(p < 0.05) to 154% of basal prostacyclin production after 60 minutes. Catalase treatment 
resulted in recovery to 105% (p < 0.05) of basal prostacyclin production within 30 
minutes of reoxygenation. Allopurinol treatment resulted in 77% recovery (p < 0.05) of 
basal prostacyclin production only during 30 minutes of reoxygenation. Dinitrophenol 
treatment resulted in significant (> 85%, p < 0.05) sustained recovery of basal prostacy- 
clin production at 30, 60, and 90 minutes of experimental reperfusion. 
Conclusions: The hypoxia-induced decrease in EC prostacyclin does not recover during 
reoxygenation. Catalase/SOD allowed return to baseline prostacyclin production during 
reoxygenation, implicating reactive oxygen metabolites as mediators of decreased 
eicosanoid biosynthesis. Recovery of prostacyclin production after 60 minutes reoxygen- 
ation with dinitrophenol but not allopurinol suggests a mitochondrial origin of the oxygen 
metabolites responsible for decreased prostacyelin biosynthesis. (J VAsc SURG 
1996;23:95-103.) 
Reactive oxygen, metabolites have been impli- 
cated as mediators of  tissue injury and necrosis during 
reperfusion injury. Scavengers of  these oxygen spe- 
cies have been shown to ameliorate postischemic 
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necrosis in myocardial, intestine, and skeletal muscle 
models.~-3 Superoxide ion and hydrogen peroxide are 
among the metabolites believed to mediate lethal 
tissue injury during reperfusion injury. *,s These 
reactive oxygen metabolites may be released by 
neutrophils. 6 Because endothelial cells (EC) are 
located at the blood tissue interface, they may be 
primary targets of  postischemic njury. 7 In fact, EC 
have been shown to be functionally sensitive to 
exogenous reactive oxygen metabolites, s,9Extensive 
microscopic studies of the microcirculation i post- 
ischemic organs document parenchymal necrosis but 
fail to demonstrate evidence of  EC death. ~~ These 
findings suggest that EC dysfunction rather than EC 
death may be a more frequent consequence of  
reperfusion injury. 
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The studies described herein were designed to 
determine whether endogenous reactive oxygen me- 
tabolites contribute to sublethal arge vessel EC 
dysfunction. We studied prostacyclin because it is a 
powerful vasodilator and inhibitor of platelet aggre- 
gation. Prostacyclin is synthesized from arachidonic 
acid liberated from membrane phospholipids and 
secreted by ECs. 1~ Prostacyclin and stable prostacy- 
clin analogues have been administered to ischemic 
heart and skeletal muscle in in vivo models of experi- 
mental reperfusion i jury. ~2'~3 In all of these studies, 
there has been a significant decrease in postischemic 
injury in the presence of these agents. One of the 
major mechanisms by which prostacyclin and pros- 
tacyclin analogues are believed to work is by inhib- 
iting neutrophil activation, thereby protecting tissues 
from neutrophil-mediated injury. 143s 
Because neutrophils have been implicated as the 
major source of exogenous reactive oxygen metabo- 
lites, an attempt is made to determine whether 
endogenous reactive oxygen metabolites mediate 
changes in large-vessel EC prostacyclin production 
during reoxygenation by treating the cells with 
catalase and superoxide dismutase (SOD). In capil- 
lary endothelium a major source of endogenous 
reactive oxygen metabolites i believed to be from 
xanthine oxidase. ~6 To determine whether xanthine 
oxidase plays a role in large-vessel endothelial dys- 
function, the cells were treated with the xanthine 
oxidase inhibitor allopurinol during reoxygenation. 
Finally, the mitochondria have been implicated as an 
important source of endogenous reactive oxygen 
metabolites in myocardial cells. 17 To determine 
whether mitochondria in large-vessel ndothelium 
provide a source of reactive oxygen metabolites, cells 
were treated with the mitochondrial uncoupler dini- 
trophenol during reoxygenation. 
METHODS 
Cell cultures. Primary cultures of bovine aortic 
EC were established by scraping the intimal surface of 
aortas from freshly slaughtered calves as previously 
described. ~8,I9 The cells were grown in complete 
medium (phenol red-free Dulbecco's modified Eagle 
medium [DMEM]; GIBCO, Grand Island, N.Y.), 
supplemented with 5% defined bovine calf serum 
(HYCLONE, Orem, Utah) and maintained in a 
37 ~ C CO 2 incubator. The EC were refed every 48 to 
72 hours and passaged at 1:5 ratios with 0.05% 
trypsin/0.125% ethylenediamine t traacetic acid. 
The EC identity was confirmed by the polygonal, 
monolayer structure seen by phase contrast micros- 
copy and by  the uptake of the fluorescent probe 
Di-I-Ac-LDL (Biomedical Technology Inc., Stough- 
ton, Mass.). Passage 3 through 5 cells were seeded 
onto Cytodex 3 microcarrier beads (Pharmacia, 
Piscataway, N.J.) at a 1:5 split ratio. On reaching 
confluence the serum concentration was reduced to 
0.5% for 24 hours before the experiments. 
Experimental medium. DMEM was supple- 
mented with 0.5% defined bovine calf serum, 10 
~mol/L fatty acid free albumin (Sigma Chemical Co., 
St. Louis, Mo.), penicillin (50 U/ml), and strepto- 
mycin (50 Ixg/ml; Flow Labs, Mclean, Va.). 
Cell counts. Duplicate 100 ~tl aliquots of 
sedimented beads were removed for cell counts at the 
beginning and end of the experiments. The cells were 
harvested from the beads by enzymatic and mechani- 
cal means and then counted in a solution containing 
trypan-blue on a hemacytometer. 
Experimental conditions. Microcarrier flasks 
were stirred at 20 rpm and were gassed with either 
normoxic or hypoxic gas (humidified) at 2 L/min 
during all intervals. At the end of each 30-minute 
interval, 70% of the medium in the flask was 
removed and replaced with fresh, equilibrated nor- 
moxic or hypoxic medium. Control: Cells were 
exposed to four 30-minute intervals by use of 
normoxic medium. Hypoxia: After the four control 
intervals, cells were acutely exposed to hypoxic 
medium for two 30-minute intervals. Reoxygenation: 
After hypoxia, cells were reexposed to normoxic 
medium for three 30-minute intervals. 
Apparatus. To equilibrate medium with nor- 
moxic or hypoxic gases, the medium was circulated 
through polytetrafluoroethylene tubing with a peri- 
staltic pump and dripped through glass bottles as 
previously described.19'2~ The hypoxic and normoxic 
circuits were completely separate, thereby providing 
reservoirs of normoxic and hypoxic medium. Me- 
dium in the normoxic circuit was gassed with 20% 
02, 6% CO2, 74% N 2. Medium in the hypoxic ircuit 
was equilibrated with 0% 02, 6% CO2, and 94% N 2. 
Even though gas-impermeable polytetrafluoroethyl- 
ene tubing was used to direct hypoxic medium 
through the apparatus, the 02 level in the reservoirs 
never fell below 1% to 2% (Po 2 -= 7 to 14 mm Hg). 
Microcarrier bead flask (Fig. 1.) 
The same 500 ml microcarrier bead flask (Technc, 
Princeton, N.J.) in which the cells were grown was 
used to perform the experiments. Rubber stoppers 
fitted with sterile stainless teel malleable tubing were 
fitted into each of the two glass ports on the 
microcarrier bead flasks. One stopper had two steel 
tubes: one tube to direct humidified gas into the flask, 
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Fig. 1. Microcarrier bead flask: gas-impermeable st rile stainless steel tubes are inserted into 
flask through rubber stoppers to deliver gas and medium to cells on microcarrier beads. These 
same tubes provide xit of gas from microcarrier flask, and route to remove samples of medium 
without altering oxygen tension inside flask. 
and another tube to provide a gas exit. The gas exit 
port was connected directly to a flowmeter (Gilmont 
Instrument Co., Barrington, Ill.). The other rubber 
stopper had a single stainless teel tube. On the 
outside of the flask, a three-way stopcock and glass 
syringe were attached to this single tube by a tight 
Luer lock (Becton Dickson Co., Franklin Lakes, 
N.J.). The glass syringe, stainless-steel stopcock, and 
tight Luer lock allowed infusion or removal of 
medium without ~ltering the 0 2 tension inside the 
flask. On the inside of the flask, the tip of the tubing 
was immersed in the medium and bead suspension. 
The tip of the tubing had a 100 ~m mesh (inset, Fig. 
1.) to prevent aspiration of beads (diameter 250 ~m) 
from the culture. The glass syringe was used to 
aspirate medium from the microcarrier bead flask at 
the beginning of the experiment and at the end of 
each interval. Fresh medium (normoxic or hypoxic) 
was directed from the reservoir circuits into the bead 
flasks as indicated by the experimental protocol. 
Quantitative assays 
Most of the medium aspirated from the micro- 
carrier bead flask was centrifuged at 250 g for 10 
minutes at 4 ~ C and then stored for assays as 
described below. An aliquot of medium was injected 
into an AVL Blood Gas Machine (AVL, Atlanta, 
Ga.) to assess the oxygen tension in the medium. 
Prostaglandin radioimmunoassay. Media ali- 
quots were centrifuged at250g and stored at - 80 ~ C 
for not more than 10 days before assay. Standards for 
6-keto-PGFl~ species (Advanced Magnetic, Cam- 
bridge, Mass.) were serially diluted to concentra.tions 
from 2000 to 8 pg/100 I~1 in serum-free medium 
(DMEM) supplemented with 10 txmol/L fatty acid- 
free albumin. Competitive binding assays were per- 
formed as previously described.19 
SOD-like activity assay. Xanthine and xanthine 
oxidase were used to generate 0 2 in a system 
modified from the original description by McCord 
and Fridovich. 21 Briefly, xanthine dissolved in a 
phosphate-buffered solution with ferri-cytdChrome c 
(Sigma) was mixed with a solution of xanthine 
oxidase in ethylenediamine tetraacetic acid-contain- 
ing buffer, pH 7.8. The activity of the xanthine 
oxidase was approximately 0.2 U/ml, which gave a 
rate of reduction of ferri-cytochrome c of 0.025 
absorbance units/rain (AA) in the presence of dis- 
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Table I. EC viability after experimental reperfusion 
Starting Trypan Ending Trypan blue 
Condition blue cell count (• SE) * cell count (• SE) * p Value 
Control (n = 5) 1.3 + 0.1 1.2 + 0.08 0.414 
CAT (n = 6) 1.4 _+ 0.1 1.3 • 0.09 0.315 
SOD (n = 6) 1.3 -4- 0.08 1.2 + 0.08 0.489 
SOD/CAT (n = 6) 1.5 -4- 0.14 1.4 + 0.13 0.696 
Allopurinol (n = 6) 1.3 • 0.08 1.3 • 0.06 0.735 
DNP (n = 5) 1.5 • 0.11 1.4 -+ 0.10 0.901 
CAT, Catalase; DNP, dinitrophenol. 
"106 ceUs/100 ~1 bead sediment. 
tilled water(AAH2o). The 5A at 550 nm for control 
medium, SOD, catalase, allopurinol, and dinitrophe- 
nol dissolved in medium (~A~) was monitored (in 
triplicate) within a constantly warmed (25 ~ C) 
Gilford spectrophotometer (Gilford Instruments 
Co., Oberlin, Ohio). SOD activity is directly related 
to the percent inhibition of ferri-cytochrome c 
reduction. The percent inhibition of ferri-cyto- 
chrome c reduction was calculated by the following 
equation: 
AAH20 -- AAx 
%Inh ib i t ion  = [ AAIq2o '] • 100 
Metabolic inhibitors/reactive oxygen metabo- 
lite scavengers. DMEM plus 0.5% defined bovine 
calf serum, 10 ~mol/L fatty acid free albumin was 
used as the diluent for all studies with scavengers and 
metabolic nhibitors. AUopurinol, 2,4-dinitrophenol, 
SOD, and catalase were all obtained from Sigma 
Chemical Co. Thirty minutes before reoxygenation, 
solutions were filter-sterilized, warmed to 37 ~ C, 
humidified, and gassed to a Po  2 = 140 -+ 5.7 before 
use for experimental reoxygenation. 
Statistical analysis. INSTAT (GraphPad, San 
Diego, Calif.) was used to perform analysis of 
variance (ANOVA) (Bonferroni post tests) and 
paired and unpaired t testing. All data are expressed 
as mean _+ SD unless otherwise indicated. 
RESULTS 
EC viability. EC exposed to I hour of profound 
hypoxia (Po 2 = 10.2 + 3.5 mm Hg) followed by 90 
minutes of reoxygenation did not lyse or die (Table 
I). There was no significant (p > 0.05) decrease in 
viable EC as assessed by trypan-blue xclusion. 
Treatment of EC with enzymatic inhibitors or 
scavengers of reactive oxygen metabolites had no 
effect on cell numbers. 
Temporal pattern of prostacyclin release. EC 
produced stable prostacyclin levels during control 
conditions (Fig. 2, intervals 3through 4). Within 30 
minutes of hypoxia (interval 5), prostacylin produc- 
tion decreased and became significantly diminished 
after 60 minutes (3.0 _+ 0.6 ng/106 cells vs 1.4 +_ 
0.4 ng/106 cells, n = 5, -+ SE,p < 0.05). Despite 30, 
60, and 90 minutes of reoxygenation, there was no 
significant recovery of EC prostacyclin production. 
For purposes of comparison between treatment 
groups, basal normoxic prostacyclin production was 
defined as the mean of prostacyclin production 
during intervals 2, 3, and 4. Prostacyclin production 
during hypoxia and experimental reperfusion were 
compared with the basal normoxic prostacyclin 
production. 
Hypoxic prostacyclin production. The level of 
prostacyclin production during hypoxia immediately 
before reperfusion were not significantly different 
(p = 0.47 by ANOVA) among the different control 
and experimental groups (control, 40.2% + 
12.8%; SOD, 45.5% _+ 15.0%; catalase, 31% _ 
9%; SOD/catalase, 36% __- 18%; allopurinol, 
42.5% + 16%; and dinitrophenol 34% + 5%. 
Effects of scavengers on prostacyclin produc- 
tion during experimental reperfusion. 
Superoxide dismutase. After 30 minutes of reoxy- 
genation in the presence of SOD (300 units/ml), 
prostacyclin production in endothelium did not 
recover to normoxic levels (75% + t8%, p > 0.05, 
n = 5) (Fig. 3). By 60 minutes ofreoxygenation, EC 
significantly recovered (153% + 42%,p < 0.05) to 
baseline prostacyclin production. This recovery of 
basal EC prostacyclin production was sustained at 90 
minutes (136% _+ 30%) in the presence of SOD. 
Catalase. Significant (105% _ 23%, p < 0~05, 
n = 6) recovery of basal EC prostaglandin produc- 
tion during experimental reperfusion i the presence 
of catalase (1200 units/ml) was evident after only 30 
minutes (Fig. 3). By both 60 minutes (127% + 
38%, p < 0.05) and 90 minutes (118% _+ 29%, 
p < 0.05) in the presence of catalase, there was a 
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Fig. 2. Prostacyclin release. Prostacyclin levels in medium at end of each interval, expressed in 
nanograms per 106 cells. Asterisk represents p < 0.05 interval 6 versus interval 4. 
sustained recovery of basal normoxic release of 
prostacyclin during experimental reperfusion. At 30 
minutes of reperfusion, cells treated simultaneously 
with both catalase and superoxide dismutase signifi- 
cantly (75% -+ 18% vs 119% -+ 24%, p < 0.05) 
improved recovery of prostacylin production when 
compared with SOD alone. At later time points, the 
combination treatment was no more effective than 
either agent alone. 
Effect of  metabolic inhibitors on prostacyclin 
production during experimental reperfusion. 
Allopurinol. Treatment of ECs with allopurinol 
(5 • 10 -4 mol/L)-during experimental reperfusion 
resulted in significant (77% -+ 13%,p < 0.05, n = 
6) recovery ofprostacyclin production by ECs during 
the initial 30 minutes of reoxygenation (Fig. 4). At 
later time points prostacyclin production was not 
significantly different from control (67% + 16%, 
p > 0.05). 
Dinitrophenol. Cells treated with 2,4-dinitro- 
phenol (5 x 10 -4 mol/L) recovered to 85% + 10% 
(p < 0.05, n -- 5) of normoxic levels within 30 
minutes of reperfusion (Fig. 4). By 60 and 90 
minutes of reoxygenation i the presence of dinitro- 
phenol, endothelium had recovered to 122% _ 32% 
and 132% _+ 56% ofnormoxic prostacyclin produc- 
tion, respectively. The recovery of prostacyclin pro- 
duction at 60 and 90 minutes was significantly 
(p < 0.05) greater than the recovery of cells treated 
with allopurinol. 
Ex vivo SOD-l ike activity in reperfusion me-  
d ium.  Solutions of SOD (300 units/ml, n = 3 
different solutions) in tissue culture medium inhib- 
ited the rate of ferri-cytochrome reduction by 
106% +-2% (Fig. 5). Catalase (1200 units/ml, 
n = 3) inhibited ferri-cytochrome c reduction by 
68% _+ 3.4%. Dinitrophenol (10 -4 tool/L, n = 3) 
inhibited the rate of cytochrome c reduction by.only 
23% -- 6%. Allopurinol (5 • 10 -4 tool/L, n = 3) 
decreased the rate of reduction by 43% +-4%. 
Control medium decreased the rate of reduction by 
only 1% +- 0.5% (n = 3). All solutions were signifi- 
cantly (p < 0.05) different from one another when 
compared by an ANOVA. 
D ISCUSSION 
These data confirm our earlier observat/'on 19 that 
ECs exposed to brief, yet clinically relevant condi- 
tions of hypoxia decrease their ability to produce 
prostacyclin and that reoxygenation does not result in 
recovery of prostacyclin biosynthesis. We chose to 
study prostacyclin release as an index of endothelial 
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Fig. 3. Effect of scavengers on prostacyclin production during experimental reperfusion: 
recovery of prostacyclin production expressed aspercentage ofbasal prostacyclin release. 
function for several reasons. First, it is an important 
mediator of arteriolar tone and platelet aggregation. 
Second, prostacyclin and related eicosanoids are 
secreted when they are synthesized, not stored inside 
the ECs. 11 Therefore the observed changes in the 
release of prostacyclin are metabolic responses, not 
indicators of gross cellular damage. Finally, admin- 
istration of prostacyclin and prostacyclin analogues 
during in vivo experiments of ischemia results in 
significant attenuation of postischemic cardiac and 
skeletal muscle necrosis. 12,13 We have now extended 
our original studies with work that suggests a role for 
reactive oxygen metabolites in endothelial dysfunc- 
tion subsequent to ischemia. Considerable scientific 
effort has confirmed the role of reactive oxygen 
metabolites a mediators of lethal tissue injury during 
reperfusion. 22,23 Furthermore, Whorton et al.s dem- 
onstrated that exogenous hydrogen peroxide could 
significandy inhibit porcine aortic EC prostacyclin 
production. Because our laboratory 19"2~ and others 24 
have found that endothelial prostacyclin production 
does not recover during reoxygenation, we tested for 
a role of endogenous reactive oxygen metabolites in
this diminished eicosanoid biosynthesis. Our data 
with scavcngcrs of reactive oxygen species confirm 
such a role. 
After 30 minutes of reoxygenation (Fig. 3), EC 
treated with catalase recovered prostacyclin produc- 
tion to a greater extent han cells treated with SOD. 
This finding was surprising because our ex vivo 
testing (Fig. 5) showed that catalase had less scav- 
enging activity than SOD. There are several possible 
explanations for this apparent discrepancy. First, it is 
possible that during early reoxygenation, hydrogen 
peroxide might have altered prostacyclin production 
to a greater extent than superoxide ions. Second, 
hydrogen peroxide is very lipophilic (in contrast o 
superoxide ion) and will readily cross cell mem- 
branes. 2s Hence, hydrogen peroxide may be more 
easily inactivated by extracellular catalase. Because 
neither SOD nor catalase have been shown to enter 
parenchymal cells, we hypothesize that these nzymes 
kept the extracellular concentration of reactive oxy- 
gen metabolites at a low level? A low extracellular 
concentration of reactive oxygen species may main- 
tain a sharp concentration gradient leading to in- 
creased iffusion out of the cells, thus decreasing 
intracellular injury. This extracellular effect is particu- 
larly relevant o the clinical condition because prac- 
tical methods for in vivo administration ofscavengers 
would be into the intravascular space. Our results 
suggest that intravascular dministration should pre- 
serve EC function. 
Our experiments with allopurinol and dinitro- 
phenol were designed to try and determine the source 
of the reactive oxygen metabolites generated uring 
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reoxygenation. Under ischemic/hypoxic conditions, 
xanthine dehydrogenase can be converted to xanthine 
oxidase by mechanisms that include limited proteoly- 
sis and sulfhydryl oxidation. 26 Once converted, xan- 
thine oxidase uses 02 instead o fNAD § as the electron 
donor, which results in production of both 0 2 and 
H202.  Because bovine aortic EC contain substantial 
amounts of  xanthine dehydrogenase that could be 
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converted to xanthine oxidase during reoxygenation, 
we inhibited xanthine oxidase activity in cells exposed 
to reoxygenation. 27 Fig. 4 shows that treatment of 
the cells with allopurinol resulted in transient signif- 
icant recovery at 30 minutes of reoxygenation. 
However, this recovery was not sustained by 60 and 
90 minutes of experimental reperfusion. This later 
result was surprising because allopurinol was found 
to have significantly greater ex vivo SOD-like activity 
than dinitrophenol (Fig. 5). We believe that these 
results suggest that in large-vessel endothelium, 
reactive oxygen metabolites generated by xanthine 
oxidase play a major role in inhibiting prostacyclin 
biosynthesis only during early reperfusion. 
In contrast to the results with allopurinol, treat- 
ment of cells with the mitochondrial uncoupler 
2,4-dinitrophenol resulted in rapid and sustained 
recovery of basal prostacyclin production during 
experimental reperfusion. These findings are of 
interest because under normoxic onditions, 95% of 
the oxygen consumed by cells becomes reduced (by 
four electrons to yield two molecules of H20 ) via 
mitochondrial e ectron transport. Hinkle et al.z8 have 
shown that intact mitochondria can produce hydro- 
gen peroxide, and other investigators subsequently 
showed that mitochondria can produce both super- 
oxide ion and hydrogen peroxide. 29 Hypoxic condi- 
tions can result in injured mitochondrial membranes, 
leading to increased leak of electrons, possibly 
resulting from inefficient electron transfer in injured 
mitochondrial membranes? ~ We believe that our 
results are consistent with mitochondria providing a 
major source of reactive oxygen metabolites in 
large-vessel ndothelium subjected to experimental 
reperfusion. We do not believe that our findings with 
this mitochondrial inhibitor epresents a significant, 
heretofore undescribed scavenger activity of dinitro- 
phenol. Our measurement of the scavenger activity in 
vitro shows that dinitrophenol had significantly less 
ex vivo SOD-like activity (Fig. 5) than allopurinol, 
SOD, or catalase. Because we have previously re- 
ported that ECs increase lactate production (i.e., 
index of anaerobic metabolism) during hypoxia and 
return to normoxic levels during reoxygenation, 19 we 
measured lactate production during reoxygenation in 
the presence of dinitrophenol. We found that in- 
creased lactate production remained high during 
reoxygenation in the presence of dinitrophenol (data 
not shown), suggesting that dinitrophenol did in fact 
inhibit mitochondrial respiration during reoxygen- 
ation. 
These data have been generated in a novel in vitro 
system. This in vitro system cannot replicate the exact 
in vivo conditions of ischemia and reperfusion. 
Earlier work in our laboratory documents hat in this 
model, rapid decrease in oxygen delivery and the 
onset of anaerobic metabolism is achieved. 19 How- 
ever, the effects of stasis, the accumulation of toxic 
metabolites or neutrophils on cellular function and 
viability may be underestimated. This and other in 
vitro models allow control of one or two variables for 
detailed tissue or cellular study. 
In conclusion, we believe that these data implicate 
endogenous reactive oxygen metabolites a mediators 
of sublethal aspects of aortic EC dysfunction. During 
early reoxygenation, endogenous endothelial reactive 
oxygen metabolites responsible for decreased prosta- 
cyclin production seem to be generated from both the 
mitochondria nd xanthine oxidase. In the later 
phases ofreoxygenation, reactive oxygen metabolites 
responsible for decreased prostacyclin production 
seem to be generated primarily in the mitochondria. 
These data suggest hat large vessel endothelium is
sensitive to even brief limited changes in oxygen ten- 
sion. In addition, the production of prostacyclin, an 
important vasoactive eicosanoid can be compromised 
by endogenous sources of reactive oxygen metabo- 
lites. Therapeutic modalities (i.e., anti-neutrophil an- 
tibodies and adenosine) that limit exogenous 
leukocyte-mediated sources of reactive oxygen me- 
tabolites will not address the endogenous endothelial 
sources of these toxic species, l
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